Holders over time
- NUS
- ELV
| Quarter | NUS | ELV |
|---|---|---|
| Q3 2020 | 13 holders, $460m | 30 holders, $15.0bn |
| Q4 2020 | 10 holders, $508m | 29 holders, $16.7bn |
| Q1 2021 | 7 holders, $497m | 25 holders, $18.6bn |
| Q2 2021 | 9 holders, $541m | 30 holders, $19.4bn |
| Q3 2021 | 6 holders, $233m | 26 holders, $18.5bn |
| Q4 2021 | 10 holders, $476m | 29 holders, $23.3bn |
| Q1 2022 | 7 holders, $409m | 31 holders, $23.9bn |
| Q2 2022 | 7 holders, $366m | 32 holders, $23.3bn |
| Q3 2022 | 5 holders, $268m | 34 holders, $22.6bn |
| Q4 2022 | 5 holders, $287m | 34 holders, $25.5bn |
| Q1 2023 | 3 holders, $238m | 39 holders, $22.5bn |
| Q2 2023 | 3 holders, $98m | 38 holders, $20.6bn |
| Q3 2023 | 5 holders, $77m | 34 holders, $19.8bn |
| Q4 2023 | 5 holders, $49m | 36 holders, $20.3bn |
| Q1 2024 | 1 holders, $264k | 35 holders, $21.3bn |
| Q2 2024 | 1 holders, $515k | 33 holders, $22.1bn |
| Q3 2024 | 1 holders, $580k | 30 holders, $20.2bn |
| Q4 2024 | 1 holders, $299k | 32 holders, $15.9bn |
| Q1 2025 | none listed holders, n.a. | 28 holders, $17.1bn |
| Q2 2025 | none listed holders, n.a. | 27 holders, $14.8bn |
| Q3 2025 | 1 holders, $11m | 27 holders, $12.7bn |
| Q4 2025 | none listed holders, n.a. | 25 holders, $17.0bn |
| Q1 2026 | 1 holders, $13m | 26 holders, $13.6bn |
| Q2 2026 | none listed holders, n.a. | 28 holders, $17.7bn |
Nu Skin Enterprises Inc
- Holders
- 1
- Reported value
- $515k
- Buyers
- 1
- Sellers
- 0
Breadth +1 among 94 comparable managers.
Elevance Health Inc Formerly
- Holders
- 33
- Reported value
- $22.1bn
- Buyers
- 14
- Sellers
- 21
Breadth -7 among 94 comparable managers.
Who holds both, Q2 2024
Both (0)
No tracked manager lists every one of them.
Only NUS (1)
Only ELV (33)
AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Artisan Partners LP, Baillie Gifford & Co, Balyasny Asset Management LLC, Brevan Howard Capital Management LP, Bridgewater Associates LP, D. E. Shaw & Co., D1 Capital Partners LP, Dodge & Cox, Eisler Capital Management Ltd, ExodusPoint Capital Management LP, Fidelity (FMR LLC), First Eagle Investment Management LLC, Glenview Capital Management LLC, Holocene Advisors LP, Invesco Ltd, Jane Street Group LLC, Janus Henderson Group Ltd, Man Group PLC, Marshall Wace LLP, MFS Investment Management, Millennium Management LLC, Moore Capital Management LP, and 8 more
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.